1.
Ann Intern Med
; 143(8): 616-7; author reply 617-8, 2005 Oct 18.
Article
in English
| MEDLINE
| ID: mdl-16230736
Subject(s)
Cyclooxygenase Inhibitors/adverse effects , Myocardial Infarction/chemically induced , Prostaglandin-Endoperoxide Synthases/adverse effects , Anti-Inflammatory Agents/administration & dosage , Aspirin/administration & dosage , Cyclooxygenase 2 , Cyclooxygenase 2 Inhibitors , Cyclooxygenase Inhibitors/administration & dosage , Drug Interactions , Humans , Membrane Proteins , Prostaglandin-Endoperoxide Synthases/administration & dosage , Risk Factors
2.
CMAJ
; 173(8): 852, 2005 Oct 11.
Article
in English
| MEDLINE
| ID: mdl-16217096
Subject(s)
Cardiovascular Diseases/etiology , Cyclooxygenase Inhibitors/adverse effects , Cyclooxygenase Inhibitors/therapeutic use , Anti-Inflammatory Agents, Non-Steroidal/pharmacology , Aspirin/pharmacology , Clinical Trials as Topic , Dose-Response Relationship, Drug , Humans , Risk Factors , Thrombosis/chemically induced
3.
Nutrition
; 20(10): 950-2, 2004 Oct.
Article
in English
| MEDLINE
| ID: mdl-15474890
4.
Peginterferon alfa-2a (40 kd) and ribavirin for black American patients with chronic HCV genotype 1.
Hepatology
; 40(3): 760-1; author reply 761, 2004 Sep.
Article
in English
| MEDLINE
| ID: mdl-15349918
Subject(s)
Antiviral Agents/therapeutic use , Hepacivirus/classification , Hepatitis C, Chronic/drug therapy , Hepatitis C, Chronic/virology , Interferon-alpha/therapeutic use , Polyethylene Glycols/therapeutic use , Ribavirin/therapeutic use , Black or African American , Humans , Interferon alpha-2 , RNA, Viral/analysis , Recombinant Proteins
5.
CMAJ
; 170(12): 1772-3; author reply 1173-4, 2004 Jun 08.
Article
in English
| MEDLINE
| ID: mdl-15184313
6.
CMAJ
; 169(3): 190, 2003 Aug 05.
Article
in English
| MEDLINE
| ID: mdl-12900475